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reduction of rate (-6.9%, -10.1%, and -15.9%) and of the EDD (-9.7%, -20.5%,
-23.2%, respectively, n¼ 4-7) while no differences were observed in the TOP.
MDP and APD values were signiﬁcantly different from control only at the 0.6 mg/ml
dose; in particular APD increased by +15.7% (n¼7) and MDP became less
negative by -6.9% (4.0 mV, n¼7).The time course of the spontaneous rate decrease
proceeded with time constants of 18.4 s, 17.6 s, and 14.2 s for 0.02, 0.2, and 0.6 mg/
ml (n¼4-7), respectively. The effect of the drug was reversible upon wash-out all
concentrations.
Conclusions: Our preliminary experiments provide the ﬁrst evidence that TMYX,
a drug largely used in the treatment of cardiac arrhythmias in TCM, acts as a dose-
dependent spontaneous rate-lowering agent in SAN cells. These preliminary data also
indicate that at doses of 0.2 mg/ml or less, the chronotropic effect reﬂects a selective
action on the early diastolic “pacemaker” depolarization, and thus suggests an effect
on the If current. Since TMYX is a mixture of several pure compounds, we intend to
proceed with the identiﬁcation of the speciﬁc molecule (s) responsible for its chro-
notropic the action.
Financial support from Tianjin Zhongxin Pharmaceutical Group Co. Ltd. Le Ren
Tang Pharmaceutical Factory to MB and DD and from MURST grant PRIN
2010BWY8E9 to DD.
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Objectives: The main purpose of this study was to determine whether estrogen could
regulate cardiac B-type natriuretic peptide (BNP) expression and to examine signal
transduction pathway (s) that are involved in this process. The role of estrogen-
induced BNP expression in estrogen’s anti-hyperthrophic effect will be also investi-
gated in this study.
Methods: BNP expression and related signal pathway of neonatal rat ventricular
cardiomyocytes (NRVCs) under estrogen treatment (E2, 0.1nMw10nM) was
analyzed by real-time quantitative PCR, Western-blotting or immunoﬂuorescence.
Phenylephrine (PE) -induced cardiac hypertrophy under estrogen with or without BNP
neutralizing antibody treatment was indicated by immunostain of cardiac troponin I
and real-time quantitative PCR detection of cardiac hypertrophic markers.
Results: Our results conﬁrmed that estrogen treatment induced both cardiac BNP
mRNA transcription (1.890.18 fold vs control, n¼4, P<0.05) and protein
translation (glycosylated proBNP, 3.930.38 fold vs control ; non-glycosylated
proBNP, 1.780.29 fold vs control, n¼4, P<0.05) in a concentration-dependent
manner. Compared with control group, a higher percentage (63.312.2% vs
18.55.8%, n¼3, P<0.01) of BNP expression positive NRVCs was also observed
in estrogen treatment group, as indicated by BNP immunostaining. Our data also
shown that upregulation of BNP expression under estrogen treatment was
accompanied by Akt (2.100.16 fold vs control n¼3, P<0.01) and p38
(1.870.39 fold vs control, n¼3, P<0.05) phosphorylation but not Erk1/2.
Treatment of PI3-kinase/Akt inhibitor LY294002 or p38 MAPK inhibitor
SB203580 decreased the estrogen-induced BNP expression in NRVCs (P<0.05).
Furthermore, while E2 treatment signiﬁcantly reduced PE induced cardiomyocytes
hypertrophy (cell-surface area, PE 2.170.36 fold vs PE+E2; beta-MHC mRNA,
PE 1.760.10 fold vs PE+E2; alpha-Actin mRNA, PE 1.700.21 fold vs PE+E2,
n¼4, P<0.05), BNP speciﬁc neutralizing antibody partially reversed the ability of
estrogen to block phenylephrine-induced cell size enlargement (cell-surface area,
PE+E2+antiBNP vs PE, P>0.05) and hypertrophic marker gene upregulation (beta-
MHC mRNA, alpha-Actin mRNA, PE+E2+antiBNP mRNA, PE+E2+antiBNP vs
PE, P>0.05) in NRVCs.
Conclusions: Our study shows that estrogen enhances intracellular BNP expression in
primary cardiomyocytes. Both PI3-kinase/Akt and p38 MAPK signal pathways were
involved in estrogen-induced BNP expression. Further, our data suggests that BNP
partially mediates estrogen’s anti-hypertrophic effect on cardiomyocytes. Our study
helps to explain the higher BNP level observed in normal cycling women than men
and offers an insight into estrogen-mediated cardioprotection.
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Objectives: Angiotensin II contributes to atherogenesis and plaque vulnerability, but
the mechanisms are not fully understood. Dendritic cells are vital in both inﬂammation
and atherogenesis. To study the relationships between angiotensin II, dendritic cells,
and atherosclerosis, we investigated the effects of angiotensin II on the expression of
connexin43 in dendritic cells.
Methods: Treatment with angiotensin II increased connexin43 expression
(P<0.05) and enhanced the induction of connexin43 expression by lipopoly-
saccharide in mouse bone marrow-derived dendritic cells (P<0.05). TheC68 JACC Vol 64/16/Suppl C j Octobpro-atherogenesis effect, were attenuated by the angiotensin II type 1 receptor
blocker valsartan.
Results: In atherosclerotic plaques of mice expressing high levels of endogenous
angiotensin II ApoE-/-, generated by the 2kidney-1clip method, connexin43
expression in dendritic cells was also increased (P<0.01), accompanied by the
upregulation of the dendritic cell maturation marker CD40 (P<0.01) and vulnerable
plaque phenotypes. The in vitro and in vivo effects of angiotensin II on connexin43
expression, as well as the proatherogenesis effect, were attenuated by the angiotensin
II type 1 receptor blocker valsartan.
Conclusions: Angiotensin II may promote atherosclerosis and plaque vulnerability
by increasing the expression of connexin43 in dendritic cells and inducing the
maturation of dendritic cells through the angiotensin II type 1 receptor, thus altering
the inﬂammatory balance in favor of T helper 1 polarization.
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Objectives: Histology and electrophysiology show that the ligament of Marshall
(LOM) is richly innervated by sympathetic and parasympathetic nerves in humans and
animals. However, the effect of LOM ablation on cardiac autonomic nervous system
and ventricular electrophysiology is still unknown. To explore it, we investigate the
impact of LOM ablation on left stellate ganglion (LSG) stimulation induced blood
pressure and ventricular electrophysiology changes as well as cesium chloride (Cs)
induced ventricular arrhythmias.
Methods: In 24 anesthetized mongrel dogs, a left thoracotomy exposed the LSG
and LOM. Step 1: In 6 dogs, the maximal systolic blood pressure percent
change (MSBP%) and ventricular effective refractory period (ERP) change
induced by LSG stimulation were measured before and after LOM ablation. Step
2: 18 dogs were assigned into two groups: the control group (N¼9) and the
LOM ablation group (N¼9). Cs-induced ventricular arrhythmias were recorded
and the concentration of Cs required to induce ventricular tachycardia was
measured.
Results: LOM ablation could markedly attenuate the increase in the MSBP%
and the decrease in ventricular ERP induced by LSG stimulation (P<0.05).
During 50V LSG stimulation, the MSBP% before and after LOM ablation were
54.32% and 26.96%, respectively (P¼0.003). Compared to the control group,
the incidence of Cs-induced ventricular arrhythmias could be signiﬁcantly
decreased and the concentration of Cs required to induce ventricular tachycardia
was signiﬁcantly elevated in the LOM ablation group (1.25 vs 0.75mmol/kg,
P¼0.002).
Conclusions: Ventricular electrophysiology changes induced by LSG stimulation
could be attenuated by LOM ablation. In Cs-induced LQTS model, LOM ablation
could signiﬁcantly decrease the incidence of ventricular arrhythmias and increase the
ventricular tachycardia susceptibility. LOM may act as a conduit between left stellate
ganglion and ventricle as well as a target for treating Cs-induced LQTS.
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Objectives: Increased sympathetic activation after acute myocardial infarction (AMI)
is thought to contribute to the potential for fatal arrhythmia. However, whether local
cardiac sympathetic ablation can reduce ventricular arrhythmias (VA) is not known.
The aim of this study was to investigate the impact of the coronary sinus (CS) and
great cardiac vein peripheral nerve ablation on ventricular electrical instability in acute
myocardial infarction dogs.
Methods: Twenty one anesthetized dogs were randomly divided into sham group
(n ¼5) or MI group (MI-placebo group n¼8; MI-ablation group n¼8).The dogs were
ligated with left anterior descending branch for MI induction. The incidence and
duration of VA were monitored for 1h in 1h after ablation. The ventricular effective
refractory period (VERP) and spatial distribution of refractory periods were measured
before creating MI and in 2 h after ablation. Subsequently the ventricular ﬁbrillation
threshold (VFT) was determined in the dogs without spontaneous VF. Finally, the
tissues from around CS and great cardiac vein were removed and indicating nerve by
immumohistochemical staining of tyrosine hydroxylase (TH). Norepinephrine levels
in Coronary Sinus and ventricle tissues Stores as well as infarct size were also
detected during the experiment. The other groups were the same as the MI-ablation
group.
Results: The incidence and duration of VA in MI-ablation group were signiﬁ-
cantly lower than that MI-placebo group (P<0.05), two dogs in only MI-placebo
group died of spontaneous VF. Before creating MI, there were no statistical
differences in the VERP and spatial distribution of refractory periods between
the three groups, whereas the ventricular ERP of infarct size were prolonged
obviously and spatial distribution of refractory periods were decreased when
compared with MI-placebo group in 2 h after ablation (P<0.05), VFT also
showed a increased trend (P>0.05). During the experiment, NE levels from CSer 16–19, 2014 j GW-ICC Abstracts/Basic and Translational Medicine
